$VPHM VIROPHARMA INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in VIROPHARMA INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
VIROPHARMA INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| 14159 Capital (GP, LLC | 10% Owner | 193 | 0 | Apr 18 2005 | |||
| 14159 capital (GP), LLC | 10% Owner | 303,264 | 0 | Dec 16 2011 | |||
| 14159 Capital (GP, LLC | 10% Owner | 0 | 0 | Apr 22 2005 | |||
| 14159 capital (GP), LLC | 10% Owner | 421 | 0 | May 12 2005 | |||
| 14159 capital (GP), LLC | 10% Owner | 248,829 | 0 | May 10 2010 | |||
| AVENTIS PHARMACEUTICALS INC | 10% Owner | 2,638,100 | 0 | Jan 16 2004 | |||
| Baker Biotech Capital (GP), LLC | 10% Owner | 1,966,090 | 0 | Dec 16 2011 | |||
| BAKER BIOTECH CAPITAL GP LLC | 10% Owner | 0 | 0 | Apr 22 2005 | |||
| BAKER BIOTECH CAPITAL GP LLC | 10% Owner | 3,036 | 0 | Feb 14 2005 | |||
| Baker Biotech Capital (GP), LLC | 10% Owner | 6,253 | 0 | May 12 2005 | |||
| Baker Biotech Capital (GP), LLC | 10% Owner | 2,150,377 | 0 | Mar 01 2006 | |||
| Baker Biotech Capital (GP), LLC | 10% Owner | 1,765,213 | 0 | May 13 2011 | |||
| BAKER BIOTECH CAPITAL II GP LLC | 10% Owner | 193 | 0 | Apr 22 2005 | |||
| Baker Biotech Capital II (GP), LLC | 10% Owner | 5,735 | 0 | May 12 2005 | |||
| Baker Biotech Capital II (GP), LLC | 10% Owner | 1,957,127 | 0 | Mar 01 2006 | |||
| Baker Biotech Capital II (Z) (GP), LLC | 10% Owner | 103,540 | 0 | Mar 01 2006 | |||
| Baker Biotech Capital III (GP), LLC | 10% Owner | 1,648,599 | 0 | Mar 01 2006 | |||
| Baker Biotech Capital III (Z) (GP), LLC | 10% Owner | 122,122 | 0 | Mar 01 2006 | |||
| Baker Biotech Capital III (Z) (GP), LLC | 10% Owner | 0 | 0 | Apr 22 2005 | |||
| BAKER BROS CAPITAL GP LLC | 10% Owner | 605 | 0 | Apr 22 2005 | |||
| Baker Bros. Capital (GP), LLC | 10% Owner | 1,246 | 0 | May 12 2005 | |||
| Baker Bros. Capital (GP), LLC | 10% Owner | 233,034 | 0 | Mar 01 2006 | |||
| Baker Bros. Capital (GP), LLC | 10% Owner | 4,751 | 0 | May 13 2011 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 9,080,664 | 0 | Apr 30 2010 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 9,840,469 | 0 | Dec 16 2011 | |||
| BAKER TISCH CAPITAL GP LLC | 10% Owner | 0 | 0 | Apr 22 2005 | |||
| BAKER TISCH CAPITAL GP LLC | 10% Owner | 301 | 0 | Feb 14 2005 | |||
| Baker / Tisch Capital (GP), LLC | 10% Owner | 605 | 0 | May 12 2005 | |||
| Baker / Tisch Capital (GP), LLC | 10% Owner | 223,686 | 0 | Mar 01 2006 | |||
| Baker / Tisch Capital (GP), LLC | 10% Owner | 1,306 | 0 | May 13 2011 | |||
| BALDINO FRANK JR | Director | 0 | 0 | Feb 23 2010 | |||
| BALDINO FRANK JR | Director | 0 | 0 | Feb 22 2006 | |||
| BROOKE PAUL A | Director | 0 | 0 | Jan 28 2014 | |||
| Broom Colin MD | VP & Chief Scientific Officer | 0 | 0 | May 12 2004 | |||
| Broom Colin MD | VP & Chief Scientific Officer | 12,103 | 0 | Sep 16 2008 | |||
| Broom Colin MD | VP & Chief Scientific Officer | 0 | 0 | Jan 28 2014 | |||
| CLAYPOOL WILLIAM D MD | Director | 40,000 | 0 | Feb 27 2008 | |||
| CLAYPOOL WILLIAM D MD | Director | 0 | 0 | Jan 28 2014 | |||
| DE ROSEN MICHEL | Chief Executive Officer | 0 | 0 | Feb 05 2004 | |||
| DE ROSEN MICHEL | Director | 437,777 | 0 | Apr 02 2008 | |||
| DE ROSEN MICHEL | Director | 137,100 | 0 | Nov 12 2008 | |||
| DOUGHERTY MICHAEL R | Director | 0 | 0 | Feb 27 2008 | |||
| DOUGHERTY MICHAEL R | Director | 0 | 0 | Jan 28 2014 | |||
| DOYLE THOMAS F | VP Strategic Initiatives | 42,682 | 0 | Jun 17 2008 | |||
| DOYLE THOMAS F | VP Strategic Initiatives | 0 | 0 | Jan 28 2014 | |||
| FARLEY RICHARD | VP, Human Resources | 0 | 0 | Mar 22 2004 | |||
| Fletcher Robert C. | V.P., Business Development | 0 | 0 | Jan 28 2014 | |||
| GLASER ROBERT | Director | 0 | 0 | Feb 10 2005 | |||
| GLASER ROBERT | Director | 38,860 | 0 | Feb 27 2008 | |||
| GLASER ROBERT | Director | 0 | 0 | Jan 28 2014 | |||
| Kirby John J. | V.P., Chief Accounting Officer | 0 | 0 | Jan 28 2014 | |||
| Leone John R | Director | 2,000 | 0 | Feb 27 2008 | |||
| Leone John R | Director | 0 | 0 | Jan 28 2014 | |||
| McHugh Julie | Director | 0 | 0 | Jan 28 2014 | |||
| MCKINLAY MARK | VP Research & Development | 0 | 0 | Apr 13 2004 | |||
| MILANO VINCENT | President, CEO & CFO | 60,942 | 0 | Jun 17 2008 | |||
| MILANO VINCENT | President and CEO | 0 | 0 | Jan 28 2014 | |||
| Morris Richard Steven | Chief Accounting Officer | 392 | 0 | Sep 15 2008 | |||
| Morris Richard Steven | Chief Accounting Officer | 1,244 | 0 | Jun 06 2012 | |||
| PIEN HOWARD H | Director | 0 | 0 | Feb 27 2008 | |||
| PIEN HOWARD H | Director | 0 | 0 | Jan 28 2014 | |||
| Pietrusko Robert | VP, Regulatory & Quality | 0 | 0 | Jun 17 2008 | |||
| Pietrusko Robert | VP, Regulatory & Quality | 0 | 0 | Jan 28 2014 | |||
| Rowland Charles A Jr | Chief Financial Officer | 0 | 0 | Oct 21 2008 | |||
| Rowland Charles A Jr | VP, Chief Financial Officer | 0 | 0 | Jan 28 2014 | |||
| SOLAND DANIEL B | VP, Chief Operating Officer | 40,000 | 0 | Jun 17 2008 | |||
| SOLAND DANIEL B | VP, Chief Operating Officer | 0 | 0 | Jan 28 2014 | |||
| Tarnoff Joshua M | VP, Commercial | 0 | 0 | Aug 26 2004 | |||
| Tarnoff Joshua M | VP, Chief Commerical Officer | 1,500 | 0 | Aug 07 2006 | |||
| Wolf John Peter III | VP, General Counsel | 0 | 0 | Jun 17 2008 | |||
| Wolf John Peter III | VP, General Counsel | 0 | 0 | Jan 28 2014 |